Vikneswari Rajasegaran

11 Hospital Drive
Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

A Protocol for Spatial Transcriptomics Using the 10× Genomics Visium Platform.

A Protocol for Spatial Transcriptomics Using the 10× Genomics Visium Platform.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 30, 2026

Inhibition of inflammation and senescence with azole compound C7 enables expansion of hematopoietic stem and progenitor cells.

Inhibition of inflammation and senescence with azole compound C7 enables expansion of hematopoietic stem and progenitor cells.

Journal: Stem cells translational medicine

Published: October 02, 2025

Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability.

Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability.

Journal: EMBO molecular medicine

Published: February 19, 2024

Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors.

Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors.

Journal: Frontiers in oncology

Published: August 04, 2023

A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers-Analytical validation and performance evaluation with clinical samples.

A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers-Analytical validation and performance evaluation with clinical samples.

Journal: Frontiers in molecular biosciences

Published: June 07, 2022

Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer.

Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer.

Journal: Prostate cancer and prostatic diseases

Published: March 15, 2022

NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer.

NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer.

Journal: Prostate cancer and prostatic diseases

Published: November 05, 2021

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia

Published: March 09, 2021

Bizarre giant cells in human angiosarcoma exhibit chemoresistance and contribute to poor survival outcomes.

Bizarre giant cells in human angiosarcoma exhibit chemoresistance and contribute to poor survival outcomes.

Journal: Cancer science

Published: August 30, 2020

Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing.

Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: August 20, 2020

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia

Published: May 21, 2020

Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.

Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.

Journal: JCO global oncology

Published: April 22, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026